Abstract: Polypeptides encoded by genes of papillomavirus HPV39 are provided. Also provided are antibodies directed to the polypeptides, and methods for diagnosing genital neoplasias and for detecting infection by HPV39.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
September 9, 1997
Assignees:
Institut National de la Sante et de la Recherche Medicale, Institut Pasteur
Inventors:
Gerard Orth, Christoph Volpers, Rolf E. Streeck
Abstract: The invention concerns DNA fragments derived from the genomic DNA of HPV-33. These fragments are selected from the group of fragments extending between the nucleotide extremities defined hereafter in relation to the nucleotide-numbering in FIGS. 1a and 1b respectively:76-556543-864867-28112728-38083326-35753842-40794198-56115516-8091.The invention also relates to the use of these fragments as probes for the detection of HPV in tissue cultures.
Abstract: The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines.
Type:
Grant
Filed:
October 6, 1994
Date of Patent:
April 8, 1997
Assignee:
The United States of America as represented by the Department of Health and Human Services
Inventors:
Douglas R. Lowy, John T. Schiller, Heather Greenstone